BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32007365)

  • 1. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
    Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models.
    Kallis K; Mayadev J; Covele B; Brown D; Scanderbeg D; Simon A; Frisbie-Firsching H; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
    Brachytherapy; 2021; 20(6):1323-1333. PubMed ID: 34607771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.
    Serban M; Fokdal L; Nielsen SK; Hokland SB; Hansen AT; Spejlborg H; Rylander S; Petric P; Lindegaard JC; Tanderup K
    Brachytherapy; 2021; 20(4):796-806. PubMed ID: 33994344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of brachytherapy applicators geometry on dose distribution in cervical cancer.
    Senkus-Konefka E; Kobierska A; Jassem J; Serkies K; Badzio A
    Strahlenther Onkol; 1997 Jun; 173(6):323-9. PubMed ID: 9209530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
    Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
    Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
    Hsu IC; Speight J; Hai J; Vigneault E; Phillips T; Pouliot J
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):538-43. PubMed ID: 11872302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
    Vinod SK; Caldwell K; Lau A; Fowler AR
    J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium.
    Kumar NP; Kumar A; Jayaprakash PG; Raghukumar P; James FV
    J Cancer Res Ther; 2018; 14(6):1191-1195. PubMed ID: 30488828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
    Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
    Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric evaluation of image based brachytherapy using tandem ovoid and tandem ring applicators.
    Rangarajan R
    Rep Pract Oncol Radiother; 2018; 23(1):57-60. PubMed ID: 29348735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
    Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A
    Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer.
    Mai J; Erickson B; Rownd J; Gillin M
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1131-41. PubMed ID: 11704338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy.
    Scott AA; Weersink M; Liu ZA; Milosevic M; Croke J; Fyles A; Lukovic J; Rink A; Beiki-Ardakani A; Borg J; Xie J; Chan K; Ballantyne H; Skliarenko J; Conway JL; Gladwish A; Weersink RA; Han K
    Brachytherapy; 2023; 22(2):146-156. PubMed ID: 36528475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix.
    Katz A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1417-25. PubMed ID: 11121642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.